158 related articles for article (PubMed ID: 28700482)
21. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
22. The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.
Schulman G; Berl T; Beck GJ; Remuzzi G; Ritz E; Shimizu M; Shobu Y; Kikuchi M
BMC Nephrol; 2016 Sep; 17(1):141. PubMed ID: 27716149
[TBL] [Abstract][Full Text] [Related]
23. Role of preoperative serum creatinine and estimated glomerular filtration rate values in asymptomatic patients undergoing carotid endarterectomy.
Bissacco D; Catanese V; Fossati A; Salvati S; Zanella G; Carmo M; Settembrini P
J Cardiovasc Surg (Torino); 2018 Jun; 59(3):412-418. PubMed ID: 26327610
[TBL] [Abstract][Full Text] [Related]
24. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.
Heerspink HJ; Persson F; Brenner BM; Chaturvedi N; Brunel P; McMurray JJ; Desai AS; Solomon SD; Pfeffer MA; Parving HH; de Zeeuw D
Lancet Diabetes Endocrinol; 2016 Apr; 4(4):309-17. PubMed ID: 26774608
[TBL] [Abstract][Full Text] [Related]
25. Bailing Capsule combined with α-ketoacid tablets for stage 3 chronic kidney disease: Protocol of a double-blinded, randomized, controlled trial.
Hu X; Wang J; Yang H; Ji S; Li Y; Xu B; Cui H
Medicine (Baltimore); 2021 May; 100(20):e25759. PubMed ID: 34011035
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.
Barnett AH; Mithal A; Manassie J; Jones R; Rattunde H; Woerle HJ; Broedl UC;
Lancet Diabetes Endocrinol; 2014 May; 2(5):369-84. PubMed ID: 24795251
[TBL] [Abstract][Full Text] [Related]
27. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
Goicoechea M; de Vinuesa SG; Quiroga B; Verde E; Bernis C; Morales E; Fernández-Juárez G; de Sequera P; Verdalles U; Delgado R; Torres A; Arroyo D; Abad S; Ortiz A; Luño J
Cardiovasc Drugs Ther; 2018 Jun; 32(3):255-263. PubMed ID: 29943364
[TBL] [Abstract][Full Text] [Related]
28. Renal Hypoxia: An Important Prognostic Marker in Patients with Chronic Kidney Disease.
Zhou H; Yang M; Jiang Z; Ding J; Di J; Cui L
Am J Nephrol; 2018; 48(1):46-55. PubMed ID: 30048964
[TBL] [Abstract][Full Text] [Related]
29. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.
Knoll GA; Fergusson D; Chassé M; Hebert P; Wells G; Tibbles LA; Treleaven D; Holland D; White C; Muirhead N; Cantarovich M; Paquet M; Kiberd B; Gourishankar S; Shapiro J; Prasad R; Cole E; Pilmore H; Cronin V; Hogan D; Ramsay T; Gill J
Lancet Diabetes Endocrinol; 2016 Apr; 4(4):318-26. PubMed ID: 26608067
[TBL] [Abstract][Full Text] [Related]
30. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
Chen Y; Deng Y; Ni Z; Chen N; Chen X; Shi W; Zhan Y; Yuan F; Deng W; Zhong Y
Am J Kidney Dis; 2013 Dec; 62(6):1068-76. PubMed ID: 23810688
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
[TBL] [Abstract][Full Text] [Related]
33. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.
Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Erondu N; Shaw W; Barrett TD; Weidner-Wells M; Deng H; Matthews DR; Neal B
Lancet Diabetes Endocrinol; 2018 Sep; 6(9):691-704. PubMed ID: 29937267
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial.
Li P; Chen Y; Liu J; Hong J; Deng Y; Yang F; Jin X; Gao J; Li J; Fang H; Liu G; Shi L; Du J; Li Y; Yan M; Wen Y; Yang W
PLoS One; 2015; 10(5):e0126027. PubMed ID: 25938778
[TBL] [Abstract][Full Text] [Related]
35. [Efficiency of benazepril combined with wind dispelling and dampness removing chinese herbs on stage 3 chronic kidney disease with wind-dampness syndrome: a prospective study].
Fang YQ; Lu Y; Wang YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Mar; 32(3):311-6. PubMed ID: 22686073
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial.
Kou J; Wu J; Yang HT; He YN; Fang JA; Deng YY; Xie YS; Nie LF; Lin HL; Cai GY; Chen XM
Trials; 2014 Dec; 15():479. PubMed ID: 25480673
[TBL] [Abstract][Full Text] [Related]
37. The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial.
Weir MA; Walsh M; Cuerden MS; Sontrop JM; Urquhart BL; Lim YJ; Chambers LC; Garg AX
Nephrol Dial Transplant; 2023 Sep; 38(10):2192-2200. PubMed ID: 36849161
[TBL] [Abstract][Full Text] [Related]
38. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
39. Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled trial.
Silveira MAD; Teles F; Berretta AA; Sanches TR; Rodrigues CE; Seguro AC; Andrade L
BMC Nephrol; 2019 Apr; 20(1):140. PubMed ID: 31023272
[TBL] [Abstract][Full Text] [Related]
40. Effect of Vitamin B
Li Y; Spence JD; Wang X; Huo Y; Xu X; Qin X
Am J Kidney Dis; 2020 Mar; 75(3):325-332. PubMed ID: 31629573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
